<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05797675</url>
  </required_header>
  <id_info>
    <org_study_id>AAUP</org_study_id>
    <nct_id>NCT05797675</nct_id>
  </id_info>
  <brief_title>Osseodensification Plus Platelet Rich Fibrin With Simultaneous Implant Installation in Closed Sinus Lift</brief_title>
  <official_title>Osseodensification Plus Platelet Rich Fibrin With Simultaneous Implant Installation in Closed Sinus Lift : A Randomized Control Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Arab American University (Palestine)</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Arab American University (Palestine)</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      12 patients with indirect sinus lift will be selected with RBH&amp;gt;5mm , surgical procedure&#xD;
&#xD;
      =osseodensification + Prf+ implant .&#xD;
&#xD;
        1. versah drilling system (osseodensefication technique )will be used , moreover Prf will&#xD;
           be prepared by Blood collected in PRF tubes from patients then centrifuge (1300rpm&#xD;
           ,14min ) .&#xD;
&#xD;
        2. primary stability will be measured using Resonance Frequency Analysis by&#xD;
           Osstellimmediately and after 6 Mn .&#xD;
&#xD;
        3. CBCT will be taken before surgery , perioapical x-ray immediately after surgery and CBCT&#xD;
           at 6m follow up to be apple to see the differences regarding bone quality and volume.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 20, 2022</start_date>
  <completion_date type="Actual">December 30, 2022</completion_date>
  <primary_completion_date type="Actual">November 20, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>secondary stability of implant</measure>
    <time_frame>6 months</time_frame>
    <description>by osstel</description>
  </primary_outcome>
  <primary_outcome>
    <measure>bone density</measure>
    <time_frame>6 months</time_frame>
    <description>measuring and evaluating bone density by cbct</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">12</enrollment>
  <condition>Oral Sinus</condition>
  <arm_group>
    <arm_group_label>Test group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Implant therapy and closed sinus lifting with A-PRF</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>prf + osseodensification</intervention_name>
    <description>prf+ osseodensification in close sinus lift</description>
    <arm_group_label>Test group</arm_group_label>
    <other_name>platelet concentrates,</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        - medically fit non pregnant no sinus pathology&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  young patients under 18&#xD;
&#xD;
          -  sinus pathology&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>hadeel albahar, master</last_name>
    <role>Principal Investigator</role>
    <affiliation>Arab American University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hadeel Albahar</name>
      <address>
        <city>Nablus</city>
        <country>Palestinian Territory, occupied</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Palestinian Territory, occupied</country>
  </location_countries>
  <verification_date>April 2023</verification_date>
  <study_first_submitted>March 22, 2023</study_first_submitted>
  <study_first_submitted_qc>March 22, 2023</study_first_submitted_qc>
  <study_first_posted type="Actual">April 4, 2023</study_first_posted>
  <last_update_submitted>April 9, 2023</last_update_submitted>
  <last_update_submitted_qc>April 9, 2023</last_update_submitted_qc>
  <last_update_posted type="Actual">April 11, 2023</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Arab American University (Palestine)</investigator_affiliation>
    <investigator_full_name>hadeel bassam albahar</investigator_full_name>
    <investigator_title>dr</investigator_title>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

